NCT03110146View on ClinicalTrials.gov

EnSite Precision 2.1 Feasibility Study

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 4, 2017

Primary Completion Date

February 1, 2019

Study Completion Date

February 1, 2019

Conditions
Arrhythmias
Interventions
DEVICE

EnSite Precision

Ablation procedure

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT03110146 - EnSite Precision 2.1 Feasibility Study | Biotech Hunter | Biotech Hunter